Yasaman Barekatain
5PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Feb 24, 2023
Oncogenic Kras G12D specific non-covalent inhibitor reprograms tumor microenvironment to prevent and reverse early pre-neoplastic pancreatic lesions and in combination with immunotherapy regresses advanced PDAC in a CD8 + T cells dependent manner.Krishnan K Mahadevan, Kathleen M McAndrews, Valerie S LeBleu
|Feb 17, 2023
Comparative Pharmacology of a Bis-Pivaloyloxymethyl Phosphonate Prodrug Inhibitor of Enolase after Oral and Parenteral Administration.Victoria C Yan, Yasaman Barekatain, Yu-Hsi Lin
|Oct 17, 2022
Prodrugs of a 1-Hydroxy-2-oxopiperidin-3-yl Phosphonate Enolase Inhibitor for the Treatment of ENO1-Deleted Cancers.Victoria C Yan, Cong-Dat Pham, Elliot S Ballato
|Jul 06, 2022
Quantification of Phosphonate Drugs by 1H-31P HSQC Shows That Rats Are Better Models of Primate Drug Exposure than Mice.Yasaman Barekatain, Sunada Khadka, Kristen Harris
|Jul 10, 2021
Homozygous MTAP deletion in primary human glioblastoma is not associated with elevation of methylthioadenosine.Yasaman Barekatain, Jeffrey J Ackroyd, Victoria C Yan
Pageof 1
Frequent Collaborators
4 joint publications
Victoria C Yan
4 joint publications
Florian L Muller
3 joint publications
Nikunj Satani
3 joint publications
Steven W Millward
2 joint publications
Raghu Kalluri
2 joint publications
Yu-Hsi Lin
1 joint publications
Dimitra K Georgiou
1 joint publications
Elliot S Ballato
1 joint publications
Eliot I Behr
1 joint publications
Ana C deCarvalho
